Cardiology Headline News

Latin American patients with rheumatoid arthritis experience fewer serious adverse events, including major adverse cardiovascular events and malignancy, than patients who are not Latin American, according to a study.

The first implantation of a new class of total artificial heart, a rotary pump with a single moving part, was successfully completed by a team at The Texas Heart Institute, the institution reported.

Overall rates of postdischarge follow-up care after heart disease hospitalization has increased, but gaps in follow-up care for Black and Medicaid dual-eligible patients widened, researchers reported.

PHILADELPHIA — Consuming a high-sugar diet over 10 days was associated with memory issues as well as negative cardiometabolic health compared with a low-sugar diet, according to a poster presentation.

An AI algorithm had high discriminative ability in identifying pulmonary hypertension-likely patients from control patients at and before diagnosis using electrocardiogram data, according to study results.

The 2016 revisions to the United Network for Organ Sharing pediatric heart transplant allocation policy were not independently associated with a drop in waitlist mortality, researchers reported.

Bayer announced positive top-line results for the FINEARTS-HF trial of finerenone, in which the drug reduced risk for cardiovascular death and heart failure events in patients with HF with preserved or mildly reduced ejection fraction.

The Federal Trade Commission proposal to ban noncompete clauses for all workers has sent powerful ripples through the health care industry, prompting physicians of all specialties to reevaluate their career trajectories.

Teleflex announced its percutaneous transluminal coronary angioplasty perfusion balloon catheter has received FDA 510(k) clearance for balloon dilatation of coronary artery or coronary bypass graft stenoses.

Decreased intake of extra-virgin olive oil within a whole-food, plant-based diet may help to lower LDL among individuals at risk for atherosclerotic CVD, according to a study published in Journal of the American Heart Association.